Invictus MD Strategies Corp. applied to list its common shares on the Nasdaq Capital Market.
The White Rock, British Columbia-based cannabis company's application is subject to Nasdaq's approval and the satisfaction of all applicable listing and regulatory requirements.
Invictus MD's shares will trade under the INV ticker on Nasdaq. Meanwhile, its common shares will continue trading on the TSX Venture Exchange and Frankfurt Stock Exchange under the GENE and 8IS1 symbols, respectively.
In addition, Invictus will consolidate its issued and outstanding common shares on a one-for-seven ratio, reducing the company's issued and outstanding shares to 16,025,244 from 112,176,712.
The share consolidation is subject to the final confirmation of the TSX Venture Exchange.